After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Protagonist Therapeutics Inc is $2.76B. A total of 0.74 million shares were traded on the day, compared to an average of 1.21M shares.
In the most recent transaction, Ali Asif sold 1,756 shares of PTGX for 46.00 per share on Apr 22 ’25. After the transaction, the Chief Financial Officer now owns 61,065 company shares. In a previous transaction on Mar 17 ’25, Waddill William D. sold 4,000 shares at 54.25 per share. PTGX shares that Director owns now total 13,130.
Among the insiders who bought shares, WILLIAM D WADDILL acquired of 4,000 shares on Mar 17 ’25 at a per-share price of $54.78. In another insider transaction, MOLINA ARTURO MD sold 30,514 shares at $55.74 per share on Mar 13 ’25. Company shares held by the Chief Medical Officer now total 83,892.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PTGX has a high of $60.60 and a low of $24.78.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PTGX’s latest balance sheet shows that the firm has $326.90M in Cash & Short Term Investments as of fiscal 2021. There were $5.86M in debt and $44.02M in liabilities at the time. Its Book Value Per Share was $11.06, while its Total Shareholder’s Equity was $300.02M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTGX is Buy with a score of 4.80.
